eduKateSG · Why Science?
Choose safer solvents where practical and control what remains by translating toxicology into daily patient exposure
Read FDA’s final December 2021 ICH Q3C(R8) guidance through solvent classes, permitted daily exposure, concentration limits, Option 1 and Option 2 calculations, process capability, testing and lifecycle change.
Solvents make chemistry possible: they dissolve, extract, wash, crystallise and clean. They can also remain in a drug substance, excipient or product, so quality science must connect their useful role with toxicology and total patient exposure.
FDA’s December 2021 ICH Q3C(R8) guidance recommends acceptable residual-solvent amounts in pharmaceuticals. Revision 8 adds permitted daily exposures for 2-methyltetrahydrofuran, cyclopentyl methyl ether and tert-butyl alcohol.
Did you know? Q3C limits are exposure-based. The same solvent concentration can lead to different daily exposure when the amount of medicine taken per day changes.
For students, Q3C joins organic chemistry, toxicology and arithmetic. The control is strongest when solvent choice, process purge and patient dose are considered together.
Chapter index
Chapters 1–9: December 2021 Q3C(R8), residual solvents, risk classes and permitted daily exposure
- 1. Residual solvents are volatile organic chemicals left by manufacture
- 2. Q3C(R8) is final December 2021 guidance
- 3. Class 1 solvents should be avoided
- 4. Class 2 solvents have health-based PDEs
- 5. Class 3 solvents have lower toxic potential
- 6. Solvents without adequate toxicological data need justification
- 7. Option 1 provides concentration limits based on a standard dose assumption
- 8. Option 2 calculates actual daily exposure
- 9. Dose units and component contributions must stay consistent
Chapters 10–17: Option 1, Option 2, daily dose, drying, purge, specifications, supplier knowledge and change
- 10. Solvent choice is the first control
- 11. Drying and purge depend on physical chemistry
- 12. Process studies identify worst credible conditions
- 13. Analytical methods must suit volatile analytes
- 14. Supplier and excipient knowledge can reduce redundant testing
- 15. Specifications follow risk and process capability
- 16. Changes can alter solvent exposure
- 17. A complete Q3C receipt makes exposure reproducible
CHAPTER 1 OF 17 · Class the solvent
1. Residual solvents are volatile organic chemicals left by manufacture
They may be used or produced during synthesis of drug substances, excipients or drug products and are not completely removed by practical manufacturing techniques. The goal is to reduce them to acceptable levels.
The scientific value of residual solvents are volatile organic chemicals left by manufacture comes from connecting a plausible source to evidence and a patient-protective decision. They may be used or produced during synthesis of drug substances, excipients or drug products and are not completely removed by practical manufacturing techniques. The goal is to reduce them to acceptable levels. Keep this boundary visible: Class 3 means lower toxic potential, not permission for uncontrolled residues.
Try this
Build a source-to-control map for residual solvents are volatile organic chemicals left by manufacture. List every component and process source contributing to residual solvents are volatile organic chemicals left by manufacture. Add the evidence, owner and acceptance criterion. Keep this limit: Class 3 means lower toxic potential, not permission for uncontrolled residues.
A strong science note separates observation from interpretation. List every component and process source contributing to residual solvents are volatile organic chemicals left by manufacture. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
List every component and process source contributing to residual solvents are volatile organic chemicals left by manufacture. Keep this boundary visible: Class 3 means lower toxic potential, not permission for uncontrolled residues.
FDA’s official Q3C(R8) page describes final recommendations for three additional solvents. The guidance reflects ICH Step 4 endorsement from April 2021 and FDA adoption.
For q3c(r8) is final december 2021 guidance, a useful explanation shows both expected control and the response to variation. FDA’s official Q3C(R8) page describes final recommendations for three additional solvents. The guidance reflects ICH Step 4 endorsement from April 2021 and FDA adoption. Preserve this guardrail: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
Try this
Challenge the assumptions behind q3c(r8) is final december 2021 guidance. Recalculate q3c(r8) is final december 2021 guidance from concentration to total daily exposure with visible units. Test a plausible failure mode and record the result. Respect this boundary: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
A strong science note separates observation from interpretation. Recalculate q3c(r8) is final december 2021 guidance from concentration to total daily exposure with visible units. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Recalculate q3c(r8) is final december 2021 guidance from concentration to total daily exposure with visible units. Keep this boundary visible: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
These solvents have unacceptable toxicity or environmental concerns. If their use is unavoidable for a significant therapeutic advance, the rationale and tight control need strong justification.
A trustworthy account of class 1 solvents should be avoided keeps chemistry, exposure, uncertainty and lifecycle action together. These solvents have unacceptable toxicity or environmental concerns. If their use is unavoidable for a significant therapeutic advance, the rationale and tight control need strong justification. Remember: A solvent absent from a short test panel is not proven absent from the process.
Try this
Audit the lifecycle record for class 1 solvents should be avoided. Challenge purge of class 1 solvents should be avoided at worst credible scale and drying conditions. Mark what changed, why it changed and what evidence closed the question. Preserve this caution: A solvent absent from a short test panel is not proven absent from the process.
A strong science note separates observation from interpretation. Challenge purge of class 1 solvents should be avoided at worst credible scale and drying conditions. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge purge of class 1 solvents should be avoided at worst credible scale and drying conditions. Keep this boundary visible: A solvent absent from a short test panel is not proven absent from the process.
They are limited because of inherent toxicity. Each permitted daily exposure represents an acceptable intake across pharmaceutical sources under the guideline assumptions.
The scientific value of class 2 solvents have health-based pdes comes from connecting a plausible source to evidence and a patient-protective decision. They are limited because of inherent toxicity. Each permitted daily exposure represents an acceptable intake across pharmaceutical sources under the guideline assumptions. Keep this boundary visible: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
Try this
Build a source-to-control map for class 2 solvents have health-based pdes. Reassess class 2 solvents have health-based pdes after a route, supplier, formulation or dose change. Add the evidence, owner and acceptance criterion. Keep this limit: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
A strong science note separates observation from interpretation. Reassess class 2 solvents have health-based pdes after a route, supplier, formulation or dose change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reassess class 2 solvents have health-based pdes after a route, supplier, formulation or dose change. Keep this boundary visible: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
They may be regarded as less toxic and lower risk to human health at the levels described in Q3C. Good manufacturing practice and practical reduction still apply.
For class 3 solvents have lower toxic potential, a useful explanation shows both expected control and the response to variation. They may be regarded as less toxic and lower risk to human health at the levels described in Q3C. Good manufacturing practice and practical reduction still apply. Preserve this guardrail: Class 3 means lower toxic potential, not permission for uncontrolled residues.
Try this
Challenge the assumptions behind class 3 solvents have lower toxic potential. List every component and process source contributing to class 3 solvents have lower toxic potential. Test a plausible failure mode and record the result. Respect this boundary: Class 3 means lower toxic potential, not permission for uncontrolled residues.
A strong science note separates observation from interpretation. List every component and process source contributing to class 3 solvents have lower toxic potential. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
List every component and process source contributing to class 3 solvents have lower toxic potential. Keep this boundary visible: Class 3 means lower toxic potential, not permission for uncontrolled residues.
CHAPTER 6 OF 17 · Calculate exposure
6. Solvents without adequate toxicological data need justification
A solvent not classified in the tables is not automatically safe. The sponsor may need toxicological evidence and a scientifically justified control strategy.
A trustworthy account of solvents without adequate toxicological data need justification keeps chemistry, exposure, uncertainty and lifecycle action together. A solvent not classified in the tables is not automatically safe. The sponsor may need toxicological evidence and a scientifically justified control strategy. Remember: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
Try this
Audit the lifecycle record for solvents without adequate toxicological data need justification. Recalculate solvents without adequate toxicological data need justification from concentration to total daily exposure with visible units. Mark what changed, why it changed and what evidence closed the question. Preserve this caution: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
A strong science note separates observation from interpretation. Recalculate solvents without adequate toxicological data need justification from concentration to total daily exposure with visible units. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Recalculate solvents without adequate toxicological data need justification from concentration to total daily exposure with visible units. Keep this boundary visible: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
CHAPTER 7 OF 17 · Calculate exposure
7. Option 1 provides concentration limits based on a standard dose assumption
The guideline derives ppm limits using a 10-gram daily product intake assumption. Compliance of each component with Option 1 can simplify the assessment.
The scientific value of option 1 provides concentration limits based on a standard dose assumption comes from connecting a plausible source to evidence and a patient-protective decision. The guideline derives ppm limits using a 10-gram daily product intake assumption. Compliance of each component with Option 1 can simplify the assessment. Keep this boundary visible: A solvent absent from a short test panel is not proven absent from the process.
Try this
Build a source-to-control map for option 1 provides concentration limits based on a standard dose assumption. Challenge purge of option 1 provides concentration limits based on a standard dose assumption at worst credible scale and drying conditions. Add the evidence, owner and acceptance criterion. Keep this limit: A solvent absent from a short test panel is not proven absent from the process.
A strong science note separates observation from interpretation. Challenge purge of option 1 provides concentration limits based on a standard dose assumption at worst credible scale and drying conditions. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge purge of option 1 provides concentration limits based on a standard dose assumption at worst credible scale and drying conditions. Keep this boundary visible: A solvent absent from a short test panel is not proven absent from the process.
The solvent concentration in each component is combined with the maximum daily amount of that component. Total exposure across the formulation should not exceed the PDE.
For option 2 calculates actual daily exposure, a useful explanation shows both expected control and the response to variation. The solvent concentration in each component is combined with the maximum daily amount of that component. Total exposure across the formulation should not exceed the PDE. Preserve this guardrail: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
Try this
Challenge the assumptions behind option 2 calculates actual daily exposure. Reassess option 2 calculates actual daily exposure after a route, supplier, formulation or dose change. Test a plausible failure mode and record the result. Respect this boundary: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
A strong science note separates observation from interpretation. Reassess option 2 calculates actual daily exposure after a route, supplier, formulation or dose change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reassess option 2 calculates actual daily exposure after a route, supplier, formulation or dose change. Keep this boundary visible: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
CHAPTER 9 OF 17 · Build the control
9. Dose units and component contributions must stay consistent
ppm, micrograms per gram, grams per day and micrograms per day are easy to mix. A transparent worksheet with units prevents a numerically neat but scientifically wrong conclusion.
A trustworthy account of dose units and component contributions must stay consistent keeps chemistry, exposure, uncertainty and lifecycle action together. ppm, micrograms per gram, grams per day and micrograms per day are easy to mix. A transparent worksheet with units prevents a numerically neat but scientifically wrong conclusion. Remember: Class 3 means lower toxic potential, not permission for uncontrolled residues.
Try this
Audit the lifecycle record for dose units and component contributions must stay consistent. List every component and process source contributing to dose units and component contributions must stay consistent. Mark what changed, why it changed and what evidence closed the question. Preserve this caution: Class 3 means lower toxic potential, not permission for uncontrolled residues.
A strong science note separates observation from interpretation. List every component and process source contributing to dose units and component contributions must stay consistent. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
List every component and process source contributing to dose units and component contributions must stay consistent. Keep this boundary visible: Class 3 means lower toxic potential, not permission for uncontrolled residues.
Route design can avoid or replace hazardous solvents before expensive removal steps are added. Selection also considers reaction performance, impurity formation, recovery, worker safety and environmental impact.
The scientific value of solvent choice is the first control comes from connecting a plausible source to evidence and a patient-protective decision. Route design can avoid or replace hazardous solvents before expensive removal steps are added. Selection also considers reaction performance, impurity formation, recovery, worker safety and environmental impact. Keep this boundary visible: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
Try this
Build a source-to-control map for solvent choice is the first control. Recalculate solvent choice is the first control from concentration to total daily exposure with visible units. Add the evidence, owner and acceptance criterion. Keep this limit: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
A strong science note separates observation from interpretation. Recalculate solvent choice is the first control from concentration to total daily exposure with visible units. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Recalculate solvent choice is the first control from concentration to total daily exposure with visible units. Keep this boundary visible: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
CHAPTER 11 OF 17 · Build the control
11. Drying and purge depend on physical chemistry
Boiling point, vapour pressure, azeotrope formation, solubility, crystal form, particle size and equipment mass transfer affect removal. A high boiling point does not alone predict retention.
For drying and purge depend on physical chemistry, a useful explanation shows both expected control and the response to variation. Boiling point, vapour pressure, azeotrope formation, solubility, crystal form, particle size and equipment mass transfer affect removal. A high boiling point does not alone predict retention. Preserve this guardrail: A solvent absent from a short test panel is not proven absent from the process.
Try this
Challenge the assumptions behind drying and purge depend on physical chemistry. Challenge purge of drying and purge depend on physical chemistry at worst credible scale and drying conditions. Test a plausible failure mode and record the result. Respect this boundary: A solvent absent from a short test panel is not proven absent from the process.
A strong science note separates observation from interpretation. Challenge purge of drying and purge depend on physical chemistry at worst credible scale and drying conditions. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge purge of drying and purge depend on physical chemistry at worst credible scale and drying conditions. Keep this boundary visible: A solvent absent from a short test panel is not proven absent from the process.
CHAPTER 12 OF 17 · Build the control
12. Process studies identify worst credible conditions
Load, temperature, pressure, time, bed depth, airflow and endpoint affect residual levels. Scale-up should preserve the mechanism that produced acceptable purge.
A trustworthy account of process studies identify worst credible conditions keeps chemistry, exposure, uncertainty and lifecycle action together. Load, temperature, pressure, time, bed depth, airflow and endpoint affect residual levels. Scale-up should preserve the mechanism that produced acceptable purge. Remember: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
Try this
Audit the lifecycle record for process studies identify worst credible conditions. Reassess process studies identify worst credible conditions after a route, supplier, formulation or dose change. Mark what changed, why it changed and what evidence closed the question. Preserve this caution: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
A strong science note separates observation from interpretation. Reassess process studies identify worst credible conditions after a route, supplier, formulation or dose change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reassess process studies identify worst credible conditions after a route, supplier, formulation or dose change. Keep this boundary visible: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
CHAPTER 13 OF 17 · Verify through change
13. Analytical methods must suit volatile analytes
Headspace gas chromatography is common, but procedure design depends on analyte and matrix. Specificity, sample equilibration, standards, detection capability and recovery need validation.
The scientific value of analytical methods must suit volatile analytes comes from connecting a plausible source to evidence and a patient-protective decision. Headspace gas chromatography is common, but procedure design depends on analyte and matrix. Specificity, sample equilibration, standards, detection capability and recovery need validation. Keep this boundary visible: Class 3 means lower toxic potential, not permission for uncontrolled residues.
Try this
Build a source-to-control map for analytical methods must suit volatile analytes. List every component and process source contributing to analytical methods must suit volatile analytes. Add the evidence, owner and acceptance criterion. Keep this limit: Class 3 means lower toxic potential, not permission for uncontrolled residues.
A strong science note separates observation from interpretation. List every component and process source contributing to analytical methods must suit volatile analytes. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
List every component and process source contributing to analytical methods must suit volatile analytes. Keep this boundary visible: Class 3 means lower toxic potential, not permission for uncontrolled residues.
CHAPTER 14 OF 17 · Verify through change
14. Supplier and excipient knowledge can reduce redundant testing
Statements, specifications, process knowledge and periodic verification can support risk-based control. Responsibility remains with the product manufacturer to ensure total exposure is acceptable.
For supplier and excipient knowledge can reduce redundant testing, a useful explanation shows both expected control and the response to variation. Statements, specifications, process knowledge and periodic verification can support risk-based control. Responsibility remains with the product manufacturer to ensure total exposure is acceptable. Preserve this guardrail: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
Try this
Challenge the assumptions behind supplier and excipient knowledge can reduce redundant testing. Recalculate supplier and excipient knowledge can reduce redundant testing from concentration to total daily exposure with visible units. Test a plausible failure mode and record the result. Respect this boundary: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
A strong science note separates observation from interpretation. Recalculate supplier and excipient knowledge can reduce redundant testing from concentration to total daily exposure with visible units. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Recalculate supplier and excipient knowledge can reduce redundant testing from concentration to total daily exposure with visible units. Keep this boundary visible: Option 1 is based on a 10-gram daily product assumption and may not fit every exposure calculation.
CHAPTER 15 OF 17 · Verify through change
15. Specifications follow risk and process capability
Testing can be focused on solvents used or reasonably present. Limits should support the PDE at the maximum daily dose and account for contributions from all relevant components.
A trustworthy account of specifications follow risk and process capability keeps chemistry, exposure, uncertainty and lifecycle action together. Testing can be focused on solvents used or reasonably present. Limits should support the PDE at the maximum daily dose and account for contributions from all relevant components. Remember: A solvent absent from a short test panel is not proven absent from the process.
Try this
Audit the lifecycle record for specifications follow risk and process capability. Challenge purge of specifications follow risk and process capability at worst credible scale and drying conditions. Mark what changed, why it changed and what evidence closed the question. Preserve this caution: A solvent absent from a short test panel is not proven absent from the process.
A strong science note separates observation from interpretation. Challenge purge of specifications follow risk and process capability at worst credible scale and drying conditions. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge purge of specifications follow risk and process capability at worst credible scale and drying conditions. Keep this boundary visible: A solvent absent from a short test panel is not proven absent from the process.
A new supplier, route, recovery practice, drying cycle, scale, formulation or daily dose can change the calculation. Change control should revisit both concentration and total exposure.
The scientific value of changes can alter solvent exposure comes from connecting a plausible source to evidence and a patient-protective decision. A new supplier, route, recovery practice, drying cycle, scale, formulation or daily dose can change the calculation. Change control should revisit both concentration and total exposure. Keep this boundary visible: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
Try this
Build a source-to-control map for changes can alter solvent exposure. Reassess changes can alter solvent exposure after a route, supplier, formulation or dose change. Add the evidence, owner and acceptance criterion. Keep this limit: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
A strong science note separates observation from interpretation. Reassess changes can alter solvent exposure after a route, supplier, formulation or dose change. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reassess changes can alter solvent exposure after a route, supplier, formulation or dose change. Keep this boundary visible: PDE compliance does not replace good manufacturing practice or control of worker and environmental exposure.
CHAPTER 17 OF 17 · Verify through change
17. A complete Q3C receipt makes exposure reproducible
The record includes solvent inventory, class, PDE, use, sources, batch data, dose, Option 1 or 2 calculations, units, analytical method, purge studies, specifications, supplier controls, unknowns and change triggers. It shows why patient exposure is acceptable.
For a complete q3c receipt makes exposure reproducible, a useful explanation shows both expected control and the response to variation. The record includes solvent inventory, class, PDE, use, sources, batch data, dose, Option 1 or 2 calculations, units, analytical method, purge studies, specifications, supplier controls, unknowns and change triggers. It shows why patient exposure is acceptable. Preserve this guardrail: Class 3 means lower toxic potential, not permission for uncontrolled residues.
Try this
Challenge the assumptions behind a complete q3c receipt makes exposure reproducible. List every component and process source contributing to a complete q3c receipt makes exposure reproducible. Test a plausible failure mode and record the result. Respect this boundary: Class 3 means lower toxic potential, not permission for uncontrolled residues.
A strong science note separates observation from interpretation. List every component and process source contributing to a complete q3c receipt makes exposure reproducible. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
List every component and process source contributing to a complete q3c receipt makes exposure reproducible. Keep this boundary visible: Class 3 means lower toxic potential, not permission for uncontrolled residues.
Q3C residual-solvent map
| Question | Evidence to capture | Boundary to retain |
|---|---|---|
| Why is it present? | Route, material, cleaning or process source | Prefer safer choices |
| What risk class applies? | Class, toxicology and PDE | Use the current table |
| What is patient exposure? | Option 1 or component-based Option 2 | Calculate with maximum daily dose |
| How is it controlled? | Purge, testing, specifications and change | Verify the total contribution |
Science learning becomes useful when a student can show where a claim came from, why it applies and where it stops. Continue with the eduKate Science Learning Hub, compare choices in the Education Hub, and connect these habits to career pathways built from subject capabilities.
Q3C makes a solvent limit more than a number on a certificate. When chemistry reduces hazardous choices, process science demonstrates removal and exposure calculations include every relevant component, the remaining solvent can be controlled in a way that protects patients.
Primary sources and verification date
Source status checked 26 October 2026. FDA guidance describes the agency’s current thinking and does not replace applicable statutes, regulations or product-specific communication with FDA.
- FDA: Q3C(R8) Residual Solvents — Final guidance, December 2021; includes three additional PDEs.
- FDA: Full Q3C(R8) guidance PDF — Official R8 recommendations and toxicological basis.
- FDA: Q3C Tables and List — Official companion solvent tables and list; check for current maintenance updates.